{"id":422,"date":"2019-11-10T14:28:37","date_gmt":"2019-11-10T13:28:37","guid":{"rendered":"https:\/\/sclerodermie.ca\/?page_id=422"},"modified":"2024-12-15T18:28:22","modified_gmt":"2024-12-15T23:28:22","slug":"research-grants","status":"publish","type":"page","link":"https:\/\/sclerodermie.ca\/en\/research\/research-grants\/","title":{"rendered":"Research Grants"},"content":{"rendered":"<h2><span style=\"color: #cb602a;\"><span style=\"color: #007da3; font-size: 14pt;\">List of major research grants<\/span><span style=\"color: #007da3; font-size: 14pt;\">*<\/span>\u00a0<\/span><span style=\"font-size: 18pt;\"><strong style=\"color: #cb602a; font-size: 13px;\"><br \/>\n<\/strong><\/span><\/h2>\n<p>&#8220;Scleroderma Quebec provides financial support to the main scleroderma research groups in Quebec and is proud to have contributed nearly 3 673 660 $ to many highly promising research projects, which are above all, a source of hope for those who are ill.&#8221;<\/p>\n<ul>\n<li>The University of Montreal Scleroderma Research Chair, a philanthropic Chair established in 2005 at the instigation of Scleroderma Quebec and Dr. Jean-Luc Sen\u00e9cal, in partnership with the University of Montreal, its Faculty of Medicine, the CHUM and the CHUM Research Centre (CRCHUM). Clinical, basic and translational research is carried out in close collaboration with the Immunoregulation Laboratory of the CHUM Research Centre, directed by Dr. Marika Sarfati, and the Laboratory for Research in Autoimmunity (LABRAI), CRCHUM, directed by Dr. Sen\u00e9cal.\n<p>\n<\/li>\n<li>Sir Mortimer B. Davis Jewish General Hospital is a public healthcare institution managed by the CIUSSS (Integrated University Health and Social Services Center) of the Center-West of the Island of Montreal.\n<p>\n<\/li>\n<li>The Canadian Scleroderma Research Group (CSRG) at the Jewish General Hospital in Montreal, in partnership with McGill University and the Lady Davis Institute for Medical Research in Montreal, was estab[1]lished in 2004. The CSRG maintains a registry of data collected from a large number of patients. Dre Marie Hudson and several scleroderma research projects benefit from the data contained in this valuable registry.\n<p>\n<\/li>\n<li>The Scleroderma Patient-centered Intervention Network (SPIN), led by Dr. Brett Thombs, is affiliated with the Jewish General Hospita[1]land McGill University. Its mission is to work with people living with scleroderma to develop, and disseminate accessible patient interven[1]tion programs that improve quality of life and empower people with scleroderma and their loved ones.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><strong><span style=\"color: #007da3; font-size: 12pt;\">As of December 31, 2024,<\/span><\/strong><\/h2>\n<p>CHUM Research Center<br \/>\nChairholder: Sabrina Anh-Tu Hoa, M.D.<br \/>\nGrant amount: $128,660<\/p>\n<p>Sir Mortimer B. Davis Jewish General Hospital<br \/>\nResearch activity grant awarded by Scleroderma Quebec to JGH fot the 2024 research initiatives for systemic sclerosis, Dr. Marie Hudson&#8221;<br \/>\nGrant amount: $25,000<\/p>\n<p>Sir Mortimer B. Davis Jewish General Hospital<br \/>\nResearch activity grant awarded by Scleroderma Quebec to JGH for the 2024 research initiatives of the Scleroderma Patient-centered Intervention Network (SPIN), Dr. Brett Thombs.<br \/>\nGrant amount: $20,000<\/p>\n<p>&nbsp;<\/p>\n<h2><strong><span style=\"color: #007da3; font-size: 12pt;\">2023<\/span><\/strong><\/h2>\n<p>CHUM Research Center<br \/>\nChairholder: Sabrina Anh-Tu Hoa, M.D.<br \/>\nGrant amount: $155,000<\/p>\n<p>Sir Mortimer B. Davis Jewish General Hospital<br \/>\nResearch activity grant awarded by Scleroderma Quebec to JGH fot the 2023 research initiatives for systemic sclerosis, Dr. Marie Hudson&#8221;<br \/>\nGrant amount: $25,000<\/p>\n<p>Sir Mortimer B. Davis Jewish General Hospital<br \/>\nResearch activity grant awarded by Scleroderma Quebec to JGH for the 2023 research initiatives of the Scleroderma Patient-centered Intervention Network (SPIN), Dr. Brett Thombs.<br \/>\nGrant amount: $20,000<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #cb602a;\"><strong><span style=\"color: #007da3;\">2022<\/span><br \/>\n<\/strong><\/span><\/p>\n<p>CHUM Research Centre<br \/>\nChairholder: Jean-Luc Sen\u00e9cal, M.D.<br \/>\nGrant amount: $121,000<\/p>\n<p>Canadian Scleroderma Research Group<br \/>\nMaintenance and updating of the CSRG database<br \/>\nGrant amount: $25,000<\/p>\n<p>Sir Mortimer B. Davis Jewish General Hospital<br \/>\nResearch activity grant awarded by Scleroderma Quebec to JGH for the 2023 research initiatives for systemic sclerosis, Dr. Marie Hudson&#8221;<br \/>\nGrant amount: $62,500<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #cb602a;\"><strong><span style=\"color: #007da3;\">2021<\/span><br \/>\n<\/strong><\/span><\/p>\n<p>CHUM Research Centre<br \/>\nChairholder: Jean-Luc Sen\u00e9cal, M.D.<br \/>\nGrant amount: $190,000 ($155,000 to the CHUM Research Centre, and $35,000 for the purchase of the <em>BD Rhapsody<\/em>)<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #cb602a;\"><strong><span style=\"color: #007da3;\">2020<\/span><br \/>\n<\/strong><\/span><\/p>\n<p>CHUM Research Centre<br \/>\nChairholder: Jean-Luc Sen\u00e9cal, M.D.<br \/>\nGrant amount: $135,000<\/p>\n<p>Canadian Scleroderma Research Group<br \/>\nMaintenance and updating of the CSRG database<br \/>\nGrant amount: $20,000<\/p>\n<p><span style=\"color: #007da3;\"><strong>2019<\/strong><\/span><\/p>\n<p>CHUM\u00a0Scleroderma Research Chair-related subscription fund<br \/>\nChairholder: Jean-Luc Sen\u00e9cal, M.D.<br \/>\nGrant amount: $100,000 ($75,000 to the immunoregulation lab at CRCHUM and $25,000 to the Scleroderma Research Chair of the University of Montreal)<\/p>\n<p><span style=\"color: #cb602a;\"><strong><span style=\"color: #007da3;\">2018<\/span><br \/>\n<\/strong><\/span><\/p>\n<p>CHUM Research Centre<br \/>\nChairholder: Jean-Luc Sen\u00e9cal, M.D.<br \/>\nGrant amount: $25,000<\/p>\n<p>Financial support to the CHUM Research Centre for the purchase of the best version of the <em>BD FACSymphony<\/em> High Speed Analyzer system.\u00a0 This cutting-edge high parameter flow cytometer, of unparallelled capabilities enables the simultaneous measurement of up to 50 different characteristics of a single cell.\u00a0 This novel cell analyser, worth close to one and a half million dollars, still has a very limited distribution in North America.\u00a0 The BD FACSymphony will be used primarily by the scleroderma research Chair and will also be made available to all medical research teams at the CHUM Research Centre who are impatiently awaiting it.<br \/>\nGrant amount: $400,000<\/p>\n<p><span style=\"color: #007da3;\"><strong>2018-2020<\/strong><\/span><strong><br \/>\n<\/strong>Project &#8220;Precision medecine and cellular epigenomics&#8221;<br \/>\nLady Davis For Medical Research Institute &#8211; Jewish General Hospital<br \/>\nGrant amount: $45,000<\/p>\n<p><span style=\"color: #007da3;\"><strong>2018-2022<\/strong><\/span><strong><br \/>\n<\/strong>Scleroderma Patient-centered Intervention Network<br \/>\nFinancial support of the SPIN-SHARE project<br \/>\nGrant amount: $50,000<\/p>\n<p><span style=\"color: #007da3;\"><strong>2017<\/strong><\/span><br \/>\nCHUM\u00a0Scleroderma Research Chair-related subscription fund<br \/>\nChairholder: Jean-Luc Sen\u00e9cal, M.D.<br \/>\nGrant amount: $100,000<\/p>\n<p><span style=\"color: #007da3;\"><strong>2015<\/strong><\/span><br \/>\nScleroderma Research Group of the CHUM (SRG-CHUM)<br \/>\nResearch fund &#8211; Martial Koenig, M. D.<br \/>\nGrant amount: $15,000<\/p>\n<p><span style=\"color: #007da3;\"><strong>2014<\/strong><\/span><br \/>\nScleroderma Research Group of the CHUM (SRG-CHUM)<br \/>\nResearch fund &#8211; Martial Koenig, M. D.<br \/>\nGrant amount: $15,000<\/p>\n<p><strong><span style=\"color: #cb602a;\"><span style=\"color: #007da3;\">2011-2012<\/span><\/span><\/strong><br \/>\nScleroderma Research Group of the CHUM (SRG-CHUM)<br \/>\nPrincipal investigator: Jean-Luc Sen\u00e9cal, M.D.<br \/>\nResearch Project related to the work of the Scleroderma Research Chair of the Universit\u00e9 de Montr\u00e9al\u00a0<br \/>\nGrant amount: $300,000<\/p>\n<p><span style=\"color: #007da3;\"><strong>2010-2012<\/strong><\/span><br \/>\nCanadian Scleroderma Research Group (GRCS),<br \/>\nMcGill University and Montreal&#8217;s Jewish General Hospital<br \/>\nPrincipal investigator: Brett D. Thombs, Ph.D.<br \/>\nResearch Project:\u00a0<em>Consortium for clinical trials of behavioral, psychological, and educational interventions in scleroderma: Initial planning meeting &amp; Coordinator for the Scleroderma Patient-centered Intervention Network.<br \/>\n<\/em>Grant amount: 8\u00a0000 $<\/p>\n<p><span style=\"color: #007da3;\"><strong>2009-2011<\/strong><\/span><br \/>\nScleroderma Research Group of the CHUM (SRG-CHUM)<br \/>\nEstablishment grant for Martial Koenig, M.D. (recruitment of a multidisciplinary team for the SRG-CHUM).<br \/>\nGrant amount: $150,000<\/p>\n<p><span style=\"color: #007da3;\"><strong>2007-2012<\/strong><\/span><br \/>\nCanadian Scleroderma Research Group (CSRG)<br \/>\nPrincipal investigator: Murray Baron, M.D., Montreal\u2019s Jewish General Hospital <br \/>\nResearch Project: Establishment of a pan-Canadian multicenter registry of scleroderma patients <br \/>\nGrant amount: $40,000<\/p>\n<p><span style=\"color: #007da3;\"><strong>2007-2010<\/strong><\/span><br \/>\nSRG-CHUM<br \/>\nPrincipal investigator: Jean-Luc Sen\u00e9cal, M.D.<br \/>\nResearch Project: The pathologic role of autoantibodies in scleroderma lung disease Chair\u00a0<br \/>\nGrant amount: $252,000<\/p>\n<p><span style=\"color: #007da3;\"><strong>2002<\/strong><\/span><br \/>\nCHUM Scleroderma Research Group (SRG-CHUM)<br \/>\nPrincipal investigator: Jean-Luc Sen\u00e9cal, M.D.<br \/>\nResearch Project: <em>Anticentomere autoantibodies in scleroderma lung Disease<\/em>.\u00a0<br \/>\nGrant amount: $16,000<\/p>\n<p>\u00a0* during the period from 2000 onwards.<\/p>\n<p><span style=\"color: #007da3; font-size: 14pt;\">Scleroderma Quebec\u2019s\u00a0fellowships <\/span><br \/>\n<span style=\"color: #007da3; font-size: 14pt;\"> to students under the supervision of\u00a0<\/span><br \/>\n<span style=\"color: #007da3; font-size: 14pt;\"> Dr. Jean-Luc\u00a0Sen\u00e9cal, SRG-CHUM:<\/span><\/p>\n<p><span style=\"color: #007da3;\"><strong>2007-2009 <\/strong><\/span>\u00a0<br \/>\nMaster&#8217;s Scholarship<br \/>\nAmount: $35,700 <br \/>\nKarine Beauchemin, B.Sc.,\u00a0M.Sc. candidate, Department of Biomedical Sciences, Universit\u00e9 de Montr\u00e9al.<br \/>\nResearch Project: Molecular and cellular characterization of topoisomerase\u00a0DNA interaction with the cell surface of fibroblasts.<\/p>\n<p><span style=\"color: #007da3;\"><strong>2005-2006<\/strong><\/span><br \/>\nMaster&#8217;s Scholarship<br \/>\nAmount: $17,850 <br \/>\nKarine Lamy, B.Sc.,\u00a0M.Sc. candidate, Department of Biomedical Sciences, Universit\u00e9 de Montr\u00e9al.<br \/>\nResearch Project:\u00a0Characterization of the binding of the\u00a0centromeric protein\u00a0CENP-B to smooth muscle cells and its relevance to scleroderma.<\/p>\n<p><span style=\"color: #007da3;\"><strong>2004-2006<\/strong><\/span><br \/>\nFellowship Award\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0<br \/>\nAmount: $50,000<br \/>\nMartial Koenig, M. D. hospital assistant specialist (internal medicine)<br \/>\nUniversity Hospital of Saint-Etienne, France.<br \/>\nResearch projects: Autoantibodies in autoimmune myositis in French Canadians<br \/>\nDiagnostic and prognostic value of autoantibodies in isolated Raynaud\u2019s phenomenon and systemic sclerosis in French Canadians.<\/p>\n<p><span style=\"color: #007da3;\"><strong>2003-2008<\/strong><\/span><br \/>\nDoctoral Fellowship\u00a0<br \/>\nAmount: $90,000\u00a0<br \/>\nGenevi\u00e8ve Robitaille,\u00a0M.Sc., Ph.D. candidate, Department of Biomedical Sciences, Universit\u00e9 de Montr\u00e9al.<br \/>\nResearch Project:\u00a0The role of autoantibodies directed against centromere\u00a0protein B in the pathophysiology of systemic sclerosis.<\/p>\n<p><span style=\"color: #007da3;\"><strong>2003-2006<\/strong><\/span><br \/>\nDoctoral Fellowship\u00a0<br \/>\nAmount: $54,000 <br \/>\nJulie Arcand, B.Sc.,\u00a0Ph.D. candidate, Department of Biomedical Sciences, Universit\u00e9 de Montr\u00e9al.<br \/>\nResearch Project:\u00a0Characterization of the interaction of autoantibodies anti-DNA\u00a0topoisomerases\u00a0with fibroblasts in systemic sclerosis.<\/p>\n<p><span style=\"color: #007da3;\"><strong>2002-2005<\/strong><\/span><br \/>\nDoctoral Fellowship<br \/>\nAmount: $45,000<br \/>\nJill H\u00e9nault, M.Sc., Ph. D. candidate, Department of Biomedical Sciences, Universit\u00e9 de Montr\u00e9al.<br \/>\nResearch Project: The role of anti-fibroblast autoantibodies in triggering and sustaining the autoimmune cascade and its fibrogenic consequences.<\/p>\n<p><span style=\"color: #007da3;\"><strong>2002-2004<\/strong><\/span><br \/>\nMaster&#8217;s Scholarship<br \/>\nAmount: $26,000 <br \/>\nM\u00e9lanie Tremblay, B.Sc.\u00a0(Biochemistry), M.Sc. candidate, Department of Biomedical Sciences, Universit\u00e9 de Montr\u00e9al.<br \/>\nResearch Project: Identification and\u00a0characterization of a new fibroblast autoantigen involved in scleroderma.<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #007da3;\">THE SCLERODERMA RESEARCH CHAIR<\/span><\/p>\n<p>In 2005, Scleroderma Quebec has pledged a total of $1 million to the <a href=\"http:\/\/en.sclerodermie.ca\/research-group\/research-chair-in-scleroderma\/\" target=\"_blank\" rel=\"noopener noreferrer\">Scleroderma Research Chair<\/a> of the Universit\u00e9 de Montr\u00e9al in support of scleroderma research.\u00a0<\/p>\n<p>These are the amounts paid to date by Scleroderma Quebec to the Chair:<\/p>\n<p>$100,000 (April 2005), $150,000 (November 2005), $187,500 (November 2006),<br \/>\n$93,750 (January 2008), $93,750 (November 2008), $93,750 (December 2009),<br \/>\n$25,000 (October 2016), $25,000 (July 2017), $31,250 (August 2018),<br \/>\nand $25,000 (August 2019), 25 000 $ (June 2022), 25 000 $ (April 2023), <strong>25 000 $ (April 2024) :<\/strong> totaling $900,000.<\/p>\n<p>As of April 30, 2024, the fair market value of this endowed Chair is $<strong>1,739,425<\/strong>.<\/p>\n<p>&nbsp;<\/p>\n<div id=\"accordion-1\" class=\"accordion no-js\"> \n\t\t\t\t\t<h3 role=\"button\" id=\"accordion-1-t1\" class=\"accordion-title js-accordion-controller\" aria-controls=\"accordion-1-c1\" aria-expanded=\"false\" tabindex=\"0\">\n\t\t\t\t Scleroderma Quebec<\/p>\n<p>Criteria and standards for awarding grants\t\t\t<\/h3>\n\t\t\n\t\t<div id=\"accordion-1-c1\" class=\"accordion-content\" aria-hidden=\"true\">\n\t\t\t<\/p>\n<p>To learn about the Criteria and standards for awarding grants, please click <a href=\"http:\/\/en.sclerodermie.ca\/research-group\/support-for-scleroderma-research\/\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a>.<\/p>\n<p>\t\t<\/div>\n\n\t\t <\/div>\n","protected":false},"excerpt":{"rendered":"<p>List of major research grants*\u00a0 &#8220;Scleroderma Quebec provides financial support to the main scleroderma research groups in Quebec and is proud to have contributed nearly 3 673 660 $ to many highly promising research projects, which are above all, a source of hope for those who are ill.&#8221; The University of Montreal Scleroderma Research Chair, [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":26156,"menu_order":0,"comment_status":"closed","ping_status":"open","template":"page-groupe-de-recherche.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-422","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/pages\/422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/comments?post=422"}],"version-history":[{"count":48,"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/pages\/422\/revisions"}],"predecessor-version":[{"id":28656,"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/pages\/422\/revisions\/28656"}],"up":[{"embeddable":true,"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/pages\/26156"}],"wp:attachment":[{"href":"https:\/\/sclerodermie.ca\/en\/wp-json\/wp\/v2\/media?parent=422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}